Metabolic phenotypes of obesity influence triglyceride and inflammation homoeostasis

European Journal of Clinical Investigation

Volumn 44, Issue 11, 2014, Pages 1053-1064

  Perez Martinez, Pablo ^a   Alcala Diaz, Juan F ^a   Delgado Lista, Javier ^a   Garcia Rios, Antonio ^a   Gomez Delgado, Francisco ^a   Marin Hinojosa, Carmen ^a   Rodriguez Cantalejo, Fernando ^b   Delgado Casado, Nieves ^a   Perez Caballero, Ana I ^a   Fuentes Jimenez, Francisco J ^a   Camargo, Antonio ^a   Tinahones, Francisco J ^c   Ordovas, Jose M ^d,e   Perez Jimenez, Francisco ^a   Lopez Miranda, Jose ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^d IMDEA FOOD INSTITUTE   (Spain)

^e TUFTS UNIVERSITY   (United States)

Author keywords

CORDIOPREV study; Hs CRP; Metabolically healthy obesity; Phenotypic flexibility; Postprandial lipaemia; Triglycerides

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; MONOUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; PROTEIN; SATURATED FATTY ACID; TRIACYLGLYCEROL; TRIACYLGLYCEROL RICH LIPOPROTEIN; UNCLASSIFIED DRUG; FAT INTAKE; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE; BODY SIZE; CHOLESTEROL BLOOD LEVEL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FAT TOLERANCE TEST; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; INFLAMMATION; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; ADAPTATION; ADMINISTRATION AND DOSAGE; CIRCADIAN RHYTHM; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIET THERAPY; FAT INTAKE; HOMEOSTASIS; LOW FAT DIET; MEDITERRANEAN DIET; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTPRANDIAL STATE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADAPTATION, PHYSIOLOGICAL; ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; BODY SIZE; C-REACTIVE PROTEIN; CIRCADIAN RHYTHM; CORONARY DISEASE; DIET, FAT-RESTRICTED; DIET, MEDITERRANEAN; DIETARY FATS; FEMALE; HOMEOSTASIS; HUMANS; HYPERLIPIDEMIAS; INFLAMMATION; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PHENOTYPE; POSTPRANDIAL PERIOD; PROSPECTIVE STUDIES; TRIGLYCERIDES;

EID: 84925260853     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12339     Document Type: Article

References (32)

1. Ruderman NB, Schneider SH, Berchtold P. The, "metabolically-obese", normal-weight individual. Am J Clin Nutr 1981;34:1617-21.
2. Lopez-Miranda J, Perez-Martinez P. It is time to define metabolically obese but normal-weight (MONW) individuals. Clin Endocrinol (Oxf) 2013;79:314-5.
3. Calori G, Lattuada G, Piemonti L, Garancini MP, Ragogna F, Villa M et al. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care 2011;34:210-5.
4. Hamer M, Stamatakis E. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab 2012;97:2482-8.
5. van Ommen B, Keijer J, Heil SG, Kaput J. Challenging homeostasis to define biomarkers for nutrition related health. Mol Nutr Food Res 2009;53:795-804.
6. Phillips CM. Metabolically healthy obesity: definitions, determinants and clinical implications. Rev Endocr Metab Disord 2013;14:219-27.
7. Harbis A, Perdreau S, Vincent-Baudry S, Charbonnier M, Bernard MC, Raccah D et al. Glycemic and insulinemic meal responses modulate postprandial hepatic and intestinal lipoprotein accumulation in obese, insulin-resistant subjects. Am J Clin Nutr 2004;80:896-902.
8. Langsted A, Freiberg JJ, Nordestgaard BG. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation 2008;118:2047-56.
9. Kolovou GD, Mikhailidis DP, Kovar J, Lairon D, Nordestgaard BG, Ooi TC et al. Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement. Curr Vasc Pharmacol 2011;9:258-70.
10. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 2008;168:1617-24.
11. Ascaso JF, Pardo S, Real JT, Lorente RI, Priego A, Carmena R. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care 2003;26:3320-5.
12. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.
13. Mihas C, Kolovou GD, Mikhailidis DP, Kovar J, Lairon D, Nordestgaard BG et al. Diagnostic value of postprandial triglyceride testing in healthy subjects: a meta-analysis. Curr Vasc Pharmacol 2011;9:271-80.
14. Delgado-Lista J, Perez-Martinez P, Perez-Jimenez F, Garcia-Rios A, Fuentes F, Marin C et al. ABCA1 gene variants regulate postprandial lipid metabolism in healthy men. Arterioscler Thromb Vasc Biol 2010;30:1051-7.
15. Freiberg JJ, Tybjaerg-Hansen A, Jensen JS, Nordestgaard BG. Nonfasting triglycerides and risk of ischemic stroke in the general population. JAMA 2008;300:2142-52.
16. Nordestgaard BG, Freiberg JJ. Clinical relevance of non-fasting and postprandial hypertriglyceridemia and remnant cholesterol. Curr Vasc Pharmacol 2011;9:281-6.
17. Griffin BA, Minihane AM, Furlonger N, Chapman C, Murphy M, Williams D et al. Inter-relationships between small, dense low-density lipoprotein (LDL), plasma triacylglycerol and LDL apoprotein B in an atherogenic lipoprotein phenotype in free-living subjects. Clin Sci (Lond) 1999;97:269-76.
18. Mora S, Szklo M, Otvos JD, Greenland P, Psaty BM, Goff DC Jr et al. LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 2007;192:211-7.
19. El Harchaoui K, van der Steeg WA, Stroes ES, Kuivenhoven JA, Otvos JD, Wareham NJ et al. Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol 2007;49:547-53.
20. Assmann G, Schulte H. Identification of individuals at high risk for myocardial infarction. Atherosclerosis 1994;110(Suppl):S11-21.
21. Alaupovic P, Mack WJ, Knight-Gibson C, Hodis HN. The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial. Arterioscler Thromb Vasc Biol 1997;17:715-22.
22. Chapman MJ, Ginsberg HN, Amarenco P, Andreotti F, Boren J, Catapano AL et al. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J 2011;32:1345-61.
23. Kolovou GD, Kostakou PM, Anagnostopoulou KK, Cokkinos DV. Therapeutic effects of fibrates in postprandial lipemia. Am J Cardiovasc Drugs 2008;8:243-55.
24. Chan DC, Pang J, Romic G, Watts GF. Postprandial hypertriglyceridemia and cardiovascular disease: current and future therapies. Curr Atheroscler Rep 2013;15:309.
25. van Oostrom AJ, Rabelink TJ, Verseyden C, Sijmonsma TP, Plokker HW, De Jaegere PP et al. Activation of leukocytes by postprandial lipemia in healthy volunteers. Atherosclerosis 2004;177:175-82.
26. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003;112:1821-30.
27. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112:1796-808.
28. Nappo F, Esposito K, Cioffi M, Giugliano G, Molinari AM, Paolisso G et al. Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. J Am Coll Cardiol 2002;39:1145-50.
29. Jellema A, Plat J, Mensink RP. Weight reduction, but not a moderate intake of fish oil, lowers concentrations of inflammatory markers and PAI-1 antigen in obese men during the fasting and postprandial state. Eur J Clin Invest 2004;34:766-73.
30. Phillips CM, Tierney AC, Perez-Martinez P, Defoort C, Blaak EE, Gjelstad IM et al. Obesity and body fat classification in the metabolic syndrome: impact on cardiometabolic risk metabotype. Obesity (Silver Spring) 2013;21:E154-61.
31. Cruz-Teno C, Perez-Martinez P, Delgado-Lista J, Yubero-Serrano EM, Garcia-Rios A, Marin C et al. Dietary fat modifies the postprandial inflammatory state in subjects with metabolic syndrome: the LIPGENE study. Mol Nutr Food Res 2012;56:854-65.
32. Devaraj S, Singh U, Jialal I. Human C-reactive protein and the metabolic syndrome. Curr Opin Lipidol 2009;20:182-9.